Symbol: |
LCA5L
|
Description: |
Leber congenital amaurosis 5-like [Source:HGNC Symbol;Acc:1255]
|
Location: |
Chr21:40777770-40817731[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:148
Gene |
Compound |
Gen_sig |
Exp_pattern |
LCA5L |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide |
0.01 |
Up |
LCA5L |
NSC 36758 |
0.014 |
Up |
LCA5L |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.042 |
Up |
LCA5L |
ANTINEOPLASTIC-376265 |
0.048 |
Up |
LCA5L |
NSC 405361 |
0.03 |
Up |
LCA5L |
NSC 405789 |
0.043 |
Up |
LCA5L |
Morpholine-N-dithiocarbamate |
0.009 |
Up |
LCA5L |
NSC 4271 |
0.02 |
Up |
LCA5L |
NSC 58903 |
0.035 |
Up |
LCA5L |
Curromycin A.B mixture |
0.041 |
Up |
LCA5L |
Naphtho[2,1-b]furan-6,9-dione, 7-chloro-1,2-dihydro- 5-hydroxy-2-methoxy-2,4-dimethyl- |
0.024 |
Up |
LCA5L |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.012 |
Up |
LCA5L |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.045 |
Up |
LCA5L |
NSC 641594 |
0.04 |
Up |
LCA5L |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.022 |
Up |
Expression pattern: Sensitivity / Resistance
Total:10 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:1
SNP |
Gene |
SNP_location |
SNP_allele |
rs202032441 |
LCA5L |
Chr21:40777794 |
G/A |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|